• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy?术后康复的曲折之路:哪些因素会延迟恶性肿瘤肝切除术后准备恢复预期肿瘤治疗(RIOT)?
J Gastrointest Surg. 2019 Dec;23(12):2362-2371. doi: 10.1007/s11605-019-04165-5. Epub 2019 Feb 26.
2
Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection.严重术前症状延迟肝切除术后恢复意向肿瘤治疗(RIOT)的准备。
Ann Surg Oncol. 2019 Dec;26(13):4548-4555. doi: 10.1245/s10434-019-07719-8. Epub 2019 Aug 14.
3
Patient-reported outcomes after oncologic hepatic resection predict the risk of delayed readiness to return to intended oncologic therapy (RIOT).患者报告的肿瘤肝切除术后结局可预测延迟准备恢复预期肿瘤治疗(RIOT)的风险。
Eur J Surg Oncol. 2024 Jul;50(7):108396. doi: 10.1016/j.ejso.2024.108396. Epub 2024 May 11.
4
Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.回归预期肿瘤治疗(RIOT):一种评估恶性肿瘤手术治疗质量的新指标。
J Surg Oncol. 2014 Aug;110(2):107-14. doi: 10.1002/jso.23626. Epub 2014 May 21.
5
Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.结直肠肝转移行部分肝切除术后的发病率低于非部分肝切除,同时保持了等效的肿瘤学结果。
Surg Oncol. 2021 Sep;38:101631. doi: 10.1016/j.suronc.2021.101631. Epub 2021 Jul 10.
6
Faster Return to Intended Oncologic Treatment (RIOT) After Trisectionectomy Does Not Translate to Better Outcomes.三分之一肝切除术(trisectionectomy)后更快地恢复预期的肿瘤治疗(RIOT)并不能转化为更好的结果。
Am Surg. 2021 Feb;87(2):309-315. doi: 10.1177/0003134820950687. Epub 2020 Sep 16.
7
Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients.胃癌患者的术后意向性肿瘤治疗(RIOT)
J Gastrointest Surg. 2020 Jan;24(1):19-27. doi: 10.1007/s11605-019-04462-z. Epub 2019 Nov 19.
8
Simultaneous Hepatic and Visceral Resection: Preoperative Risk Stratification and Implications on Return to Intended Oncologic Therapy.同期肝和内脏切除术:术前风险分层与对恢复预期肿瘤治疗的影响。
Ann Surg Oncol. 2023 Mar;30(3):1772-1783. doi: 10.1245/s10434-022-12834-0. Epub 2022 Nov 23.
9
Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.头颈部肿瘤外科手术后的加速康复(ERAS):对计划肿瘤治疗回归(RIOT)和生存的影响。
Oral Oncol. 2022 Jul;130:105906. doi: 10.1016/j.oraloncology.2022.105906. Epub 2022 May 17.
10
Patient-Reported Outcomes Accurately Measure the Value of an Enhanced Recovery Program in Liver Surgery.患者报告结局准确衡量肝脏手术中强化康复计划的价值。
J Am Coll Surg. 2015 Dec;221(6):1023-30.e1-2. doi: 10.1016/j.jamcollsurg.2015.09.011. Epub 2015 Oct 21.

引用本文的文献

1
The impact of sugammadex versus neostigmine reversal on return to intended oncological therapy-related outcomes after breast cancer surgery: a retrospective cohort study.舒更葡糖钠与新斯的明用于乳腺癌手术后恢复预期肿瘤治疗相关结局的影响:一项回顾性队列研究。
Perioper Med (Lond). 2025 Sep 2;14(1):92. doi: 10.1186/s13741-025-00591-z.
2
Return to Intended Oncological Therapy: State of the Art and Perspectives.返回计划的肿瘤学治疗:现状与展望。
Curr Oncol Rep. 2024 Nov;26(11):1420-1430. doi: 10.1007/s11912-024-01594-7. Epub 2024 Sep 25.
3
Effect of surgical approach on early return to intended oncologic therapy after resection for pancreatic ductal adenocarcinoma.手术入路对胰腺导管腺癌切除术后早期恢复计划肿瘤学治疗的影响。
Surg Endosc. 2024 Sep;38(9):4986-4995. doi: 10.1007/s00464-024-11022-3. Epub 2024 Jul 10.
4
Exploring Hyperoxia Effects in Cancer-From Perioperative Clinical Data to Potential Molecular Mechanisms.探索高氧在癌症中的作用——从围手术期临床数据到潜在分子机制
Biomedicines. 2021 Sep 13;9(9):1213. doi: 10.3390/biomedicines9091213.
5
Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep.开发一种用于评估肝外科围手术期患者症状负担的患者报告结局工具:MDASI-PeriOp-Hep。
Eur J Oncol Nurs. 2021 Jun;52:101959. doi: 10.1016/j.ejon.2021.101959. Epub 2021 Apr 28.
6
Advances in the surgical management of gastric and gastroesophageal junction cancer.胃及胃食管交界癌手术治疗的进展
Transl Gastroenterol Hepatol. 2021 Jan 5;6:16. doi: 10.21037/tgh.2020.02.06. eCollection 2021.
7
ASO Author Reflections: The Role of the Robot in Liver Surgery: An Evolution in Progress.《美国外科医师学会(ASO)作者反思:机器人在肝脏手术中的作用:进展中的演变》
Ann Surg Oncol. 2020 Dec;27(Suppl 3):897-898. doi: 10.1245/s10434-020-09033-0. Epub 2020 Aug 19.
8
Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection.严重术前症状延迟肝切除术后恢复意向肿瘤治疗(RIOT)的准备。
Ann Surg Oncol. 2019 Dec;26(13):4548-4555. doi: 10.1245/s10434-019-07719-8. Epub 2019 Aug 14.

本文引用的文献

1
Development of a Prehabilitation Multimodal Supportive Care Interventions for Men and Their Partners Before Radical Prostatectomy for Localized Prostate Cancer.发展一种多模式支持性康复治疗干预措施,用于局部前列腺癌根治术前的男性及其伴侣。
Cancer Nurs. 2019 Jul/Aug;42(4):E47-E53. doi: 10.1097/NCC.0000000000000618.
2
Invited Editorial: The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Innovation to Implementation.
Ann Surg. 2018 Jul;268(1):19-21. doi: 10.1097/SLA.0000000000002792.
3
ERAS-Anticipated outcomes and realistic goals.加速康复外科预期结果与现实目标
J Surg Oncol. 2017 Oct;116(5):570-577. doi: 10.1002/jso.24791. Epub 2017 Sep 5.
4
Patient engagement with surgical site infection prevention: an expert panel perspective.患者参与手术部位感染预防:专家小组观点
Antimicrob Resist Infect Control. 2017 May 12;6:45. doi: 10.1186/s13756-017-0202-3. eCollection 2017.
5
Enhanced Recovery After Surgery for Noncolorectal Surgery?: A Systematic Review and Meta-analysis of Major Abdominal Surgery.非结直肠手术的术后加速康复?:一项关于大型腹部手术的系统评价和荟萃分析
Ann Surg. 2018 Jan;267(1):57-65. doi: 10.1097/SLA.0000000000002267.
6
Enhanced Recovery After Surgery: A Review.术后加速康复:综述。
JAMA Surg. 2017 Mar 1;152(3):292-298. doi: 10.1001/jamasurg.2016.4952.
7
The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.局限性前列腺癌根治性前列腺切除术后中性粒细胞与淋巴细胞比值的预后意义
Oncotarget. 2017 Feb 14;8(7):11778-11787. doi: 10.18632/oncotarget.14349.
8
Enhanced recovery after surgery programs versus traditional perioperative care in laparoscopic hepatectomy: A meta-analysis.手术康复计划与传统围手术期护理在腹腔镜肝切除术中的对比:一项荟萃分析。
Int J Surg. 2016 Dec;36(Pt A):274-282. doi: 10.1016/j.ijsu.2016.11.017. Epub 2016 Nov 10.
9
Enhanced Recovery After Surgery Programs Improve Patient Outcomes and Recovery: A Meta-analysis.术后加速康复计划改善患者预后及康复:一项荟萃分析。
World J Surg. 2017 Apr;41(4):899-913. doi: 10.1007/s00268-016-3807-4.
10
The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.术后中性粒细胞与淋巴细胞比值及其变化可预测Ⅰ期非小细胞肺癌完全切除术后的生存情况。
Onco Targets Ther. 2016 Oct 21;9:6529-6537. doi: 10.2147/OTT.S117290. eCollection 2016.

术后康复的曲折之路:哪些因素会延迟恶性肿瘤肝切除术后准备恢复预期肿瘤治疗(RIOT)?

Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy?

机构信息

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

J Gastrointest Surg. 2019 Dec;23(12):2362-2371. doi: 10.1007/s11605-019-04165-5. Epub 2019 Feb 26.

DOI:10.1007/s11605-019-04165-5
PMID:30809785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6900935/
Abstract

BACKGROUND

Poor recovery after oncologic hepatic resection delays Return to Intended Oncologic Therapy (RIOT) and shortens survival. In order to identify at-risk patients, this study was designed to determine which psychosocial and perioperative factors are associated with delayed RIOT readiness.

METHODS

A prospectively maintained database was queried to identify consecutive patients undergoing hepatectomy for malignancy from 2015 to 2017. Perioperative factors were compared between patients with early (≤ 28 postoperative days) vs. delayed (> 28 postoperative days) clearance to RIOT. Univariate analysis and multivariable logistic regression were performed.

RESULTS

Of 114 patients, 76 patients (67%) had an open surgical approach, 32 (28%) had a major hepatectomy, and 6 (5%) had a major complication, with no mortalities. Eighty-two patients (72%) had early and 32 patients (28%) had delayed RIOT readiness. Patients with high preoperative symptom burden were more likely to have delayed RIOT readiness (OR 3.1, 95% CI 1.1-8.4, p = 0.024). On multivariable analysis, open surgical approach (OR 6.9, 95% CI 1.4-34.7, p = 0.018), length of stay > 5 days (OR 3.6, 95% CI 1.4-9.4, p = 0.010), and any complication (OR 3.4, 95% CI 1.1-10.7, p = 0.033) were associated with delayed RIOT readiness. Postoperative factors associated with delayed RIOT readiness included nutritional and wound-healing parameters.

CONCLUSIONS

This study highlights the previously under-described importance of preoperative patient symptom burden on delayed postoperative recovery. As a cancer patient's return to oncologic therapy after hepatectomy has a substantial impact on survival, it is critical to adhere to enhanced recovery principles and address all other modifiable factors that delay recovery.

摘要

背景

肿瘤肝切除术后恢复不良会延迟重返肿瘤治疗(RIOT)并缩短生存期。为了确定高危患者,本研究旨在确定哪些心理社会和围手术期因素与 RIOT 准备延迟有关。

方法

对 2015 年至 2017 年间连续接受恶性肿瘤肝切除术的患者前瞻性维护的数据库进行了查询。比较了 RIOT 早期(≤28 个术后日)和延迟(>28 个术后日)清除的患者的围手术期因素。进行了单变量分析和多变量逻辑回归分析。

结果

114 例患者中,76 例(67%)采用开放手术方式,32 例(28%)行大范围肝切除术,6 例(5%)发生严重并发症,无死亡病例。82 例(72%)患者 RIOT 准备较早,32 例(28%)患者 RIOT 准备较晚。术前症状负担高的患者更有可能 RIOT 准备延迟(OR 3.1,95%CI 1.1-8.4,p=0.024)。多变量分析显示,开放手术方式(OR 6.9,95%CI 1.4-34.7,p=0.018)、住院时间>5 天(OR 3.6,95%CI 1.4-9.4,p=0.010)和任何并发症(OR 3.4,95%CI 1.1-10.7,p=0.033)与 RIOT 准备延迟有关。与 RIOT 准备延迟相关的术后因素包括营养和伤口愈合参数。

结论

本研究强调了术前患者症状负担对术后恢复延迟的重要性,这在以前的研究中被低估了。由于肝癌患者术后重返肿瘤治疗对生存有重大影响,因此必须严格遵循强化康复原则,并解决所有其他可能导致恢复延迟的可改变因素。